Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of TNFα-Kinoid in Crohn's disease
2010-019996-32Phase 2Completed
- Sponsor
- Neovacs
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing TNFα-Kinoid with Placebo (2 arms). Primary endpoint: Clinical remission by CDAI. Started Oct 2010; status: completed.
02
Drugs
tnf kinoid
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2010-019996-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019996-32.